The interactions between IL-22 and IL-17 secreted by infiltrating Th cells may contribute to the pathological development of NAFLD, and IL-22 signaling is also suggested to be associated with liver fibrosis [28]. This evidence concerns the gene IL17A and metabolic dysfunction-associated steatotic liver disease.